Support the INSULIN Act to cap insured patients' out-of-pocket insulin costs at $35 per month, prohibit deductibles on select insulin products, help uninsured people access insulin, and speed biosimilar insulin to market.

Robert P. Bresnahan, Jr. · Pennsylvania · Republican

policy impact 0.75 specificity 0.86 extraction confidence 90%

Commitment kind: unknown. Promised action: not established. Promised outcome: not established. Deadline: unknown; not assumed expired.

Contest this claim

Occurrences

Representative Diana DeGette (CO-01), Co-Chair of the Congressional Diabetes Caucus, along with Representatives Mariannette Miller-Meeks (IA-01), Kim Schrier (WA-08), Rob Bresnahan (PA-08), and Angie Craig (MN-02), introduced the Improving Needed Safeguards for Users of Lifesaving Insulin Now (“INSULIN”) Act. This bill will cap the cost of insulin at $35 per month for insured individuals. ... “This legislation isn’t just a Band-Aid on the problem. It delivers immediate relief for patients and reforms that will increase competition and drive down prices over the long term,” said Rep. Bresnahan.

Bresnahan joined the introduction of the INSULIN Act and said it would provide immediate relief and longer-term reforms to lower insulin prices.

DeGette Delivers Bill to Cap Insulin Cost at $35 Per Month | Congresswoman Diana DeGette
primary · press_release · model gpt-5.5

Evidence

legacy_unverified · Source version not recorded · locator unknown

GovInfo lists H.R. 10227 as introduced in the House on September 2, 2026, with Robert P. Bresnahan, Jr. among the cosponsors and the latest action as referral to Energy and Commerce, Ways and Means, and Education and Workforce.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Official bill metadata confirms Bresnahan was an original cosponsor of the INSULIN Act of 2026. The bill had not become law as of the listed latest action; it remained referred to committees. For a commitment framed as supporting the INSULIN Act, cosponsorship is concrete delivery of support.

delivered same_term A for effort

H.R. 10227 (IH) - Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2026
secondary · model gpt-5.5 · confidence 95%

Contest this evidence item

legacy_unverified · Source version not recorded · locator unknown

The release says DeGette, Miller-Meeks, Schrier, Rob Bresnahan, and Craig introduced the INSULIN Act, which would cap insulin cost at $35 per month for insured individuals and also prohibit deductibles, help uninsured people access insulin, and speed biosimilar insulin to market.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): An official House press release documents Bresnahan's participation in introducing the bill and describes the same core policy elements in the campaign commitment. Bresnahan also provided a supportive statement for the legislation.

delivered same_term A for effort

DeGette Delivers Bill to Cap Insulin Cost at $35 Per Month | Congresswoman Diana DeGette
primary · model gpt-5.5 · confidence 93%

Contest this evidence item

Assessments

Public state: unverified As of unknown · legacy_unverified · . Original AI recommendation (not independently established): delivered. same_term

The promise was framed as supporting the INSULIN Act, not necessarily securing enactment. During Bresnahan's current House term, he was listed as an original cosponsor/participant in introducing H.R. 10227, the INSULIN Act of 2026, with the same $35 monthly insured insulin cap, deductible prohibition, uninsured access provisions, and biosimilar-market provisions described in the claim. The bill had only been referred to committees, so the broader policy outcome was not enacted, but his promised act of support was fulfilled in the same federal term.

provider codex_cli · model gpt-5.5 · confidence 93%